Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Gross Profit: 2016-2025

Historic Gross Profit for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to $133.6 million.

  • Tg Therapeutics' Gross Profit rose 79.26% to $133.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $453.9 million, marking a year-over-year increase of 94.11%. This contributed to the annual value of $290.5 million for FY2024, which is 32.34% up from last year.
  • As of Q3 2025, Tg Therapeutics' Gross Profit stood at $133.6 million, which was up 9.33% from $122.2 million recorded in Q2 2025.
  • In the past 5 years, Tg Therapeutics' Gross Profit registered a high of $162.3 million during Q3 2023, and its lowest value of $77,000 during Q4 2022.
  • For the 3-year period, Tg Therapeutics' Gross Profit averaged around $79.2 million, with its median value being $74.5 million (2024).
  • Its Gross Profit has fluctuated over the past 5 years, first slumped by 96.68% in 2022, then soared by 176,319.57% in 2023.
  • Quarterly analysis of 5 years shows Tg Therapeutics' Gross Profit stood at $2.3 million in 2021, then plummeted by 96.68% to $77,000 in 2022, then surged by 46,805.19% to $36.1 million in 2023, then surged by 156.90% to $92.8 million in 2024, then spiked by 79.26% to $133.6 million in 2025.
  • Its Gross Profit stands at $133.6 million for Q3 2025, versus $122.2 million for Q2 2025 and $105.3 million for Q1 2025.